Centrifugal Blood Pump Global Market Insights 2026, Analysis and Forecast to 2031

April 2026 | 109 pages | ID: CDFD76EFF688EN
Prof Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global cardiovascular surgery and critical care sectors operate at the absolute frontier of medical engineering, where devices must flawlessly replicate complex human physiological functions. Within this ultra-high-acuity environment, the Centrifugal Blood Pump functions as an extraordinarily critical, life-sustaining medical device. Utilizing a rapidly rotating, bladed or smooth impeller, these devices generate centrifugal force to continuously propel blood through an extracorporeal circuit. They are fundamentally engineered to temporarily support or entirely replace the pumping function of the human heart. Deployed universally in Cardiopulmonary Bypass (CPB) during open-heart surgery, long-term Extracorporeal Membrane Oxygenation (ECMO) for severe respiratory or cardiac failure, and as permanent Ventricular Assist Devices (VADs), centrifugal pumps represent the pinnacle of biocompatible fluid dynamics.

Current macroeconomic intelligence and global cardiovascular disease metrics project a highly specialized, technology-driven growth trajectory for this critical device segment. The global Centrifugal Blood Pump market size is projected to achieve an estimated valuation ranging between 63 million USD and 96 million USD by the year 2026. This highly concentrated market valuation accurately reflects the device's status as a low-volume, ultra-premium, life-support capital and consumable equipment hybrid. Projecting forward into the next decade, the industry is anticipated to expand at a Compound Annual Growth Rate (CAGR) of 4.2% to 6.5% through the forecast period extending to 2031.

This steady, highly reliable growth band is structurally tethered to compounding global cardiovascular demographics. The aging global population is driving an unavoidable surge in severe heart failure, valvular disease, and the necessity for complex cardiac bypass surgeries. Furthermore, the global proliferation of ECMO as a critical rescue therapy for acute respiratory distress—a trend massively accelerated by recent global viral pandemics—cements the baseline demand for these advanced pumps. Centrifugal pumps are overwhelmingly replacing legacy roller pumps because they provide a continuous, non-pulsatile blood flow (typically 2-8 L/min) that dramatically reduces catastrophic red blood cell destruction (hemolysis) and systemic inflammatory responses. This report provides an exhaustive, data-driven analysis of the regional market dynamics, technological segmentations, value chain structures, and the competitive landscape shaping the strategic future of the Centrifugal Blood Pump industry.

Regional Market Analysis

The global distribution of centrifugal blood pump consumption is strictly dictated by the presence of advanced tertiary cardiac centers, high regional healthcare expenditure, and the availability of highly trained perfusionists and cardiovascular surgeons.

North America

North America operates as the most mature and value-dense market for advanced extracorporeal life support, driven by a massive domestic cardiovascular disease burden and cutting-edge surgical infrastructure.
  • United States: The US market is fundamentally shaped by the highest volume of open-heart surgeries globally and a massive, heavily funded heart failure and transplant ecosystem. The US market dictates technological trends, exhibiting a total shift toward advanced, magnetically levitated centrifugal pumps for ECMO and VADs. The massive capital availability of US hospital networks ensures the continuous procurement of these premium life-support systems to outfit specialized Cardiac Intensive Care Units (CICUs).
Europe

The European market is a global leader in advanced critical care protocols and decentralized ECMO retrieval networks.
  • Western Europe: Countries such as Germany, France, and the UK possess highly integrated national healthcare systems. Europe leads the world in the deployment of mobile ECMO teams, requiring ultra-compact, highly reliable electronic centrifugal pumps that can operate seamlessly during ambulance or helicopter transport of critically ill patients. Germany’s massive concentration of world-class cardiac surgery centers drives significant regional volume demand.
Asia-Pacific

The Asia-Pacific basin is the most dynamic growth frontier for the global centrifugal blood pump market, driven by rapidly expanding healthcare infrastructure and an aging demographic.
  • Japan: Japan represents a highly mature, ultra-premium market. With the world's oldest population, Japan faces surging rates of advanced heart failure. Cultural and legal restrictions historically limiting heart transplants have driven Japan to become a global pioneer and massive consumer of long-term, implantable centrifugal VADs as destination therapy.
  • China and India: As the center of gravity for global population dynamics, these nations are rapidly expanding their tertiary cardiac care capabilities. The sheer scale of the population suffering from congenital and acquired heart disease necessitates the rapid construction of new cardiac surgical suites, driving the bulk procurement of cost-effective mechanical and electronic centrifugal pumps for foundational Cardiopulmonary Bypass (CPB) procedures.
South America & Middle East & Africa (MEA)

These regions represent emerging, specialized consumption hubs driven by localized infrastructure mega-projects in healthcare.
  • GCC Countries: Massive state investments in building futuristic, world-class specialized cardiac centers in Saudi Arabia and the UAE are pulling premium, top-tier centrifugal pump technology into the region, establishing localized hubs of advanced extracorporeal life support.
Market Segmentation

The Centrifugal Blood Pump market is highly segmented by driving mechanism and clinical application, reflecting the intense engineering required for different durations of extracorporeal support.

Type
  • Electronic (Magnetically Levitated) Pumps: The absolute premium, high-growth segment. These pumps utilize advanced electromagnets to suspend the spinning impeller entirely in mid-air within the blood chamber, completely eliminating physical bearings. This frictionless design dramatically minimizes sheer stress on red blood cells, drastically reducing hemolysis and thrombus (clot) formation. They are the mandatory standard for multi-week ECMO support and permanent VAD implantation.
  • Mechanical (Bearing-Supported) Pumps: The foundational, high-volume segment. These pumps utilize a physical bearing and seal to support the spinning impeller. While they cause slightly higher hemolysis than magnetically levitated pumps, they are highly cost-effective and perfectly suited for short-term Cardiopulmonary Bypass (CPB) during typical 3-to-6 hour open-heart surgeries.
Application
  • Hospitals (Cardiac Surgery & ICUs): The dominant volume consumer. Centrifugal pumps are utilized daily in cardiac operating rooms for CPB, temporarily taking over the heart and lungs to provide surgeons with a bloodless, motionless surgical field. In the ICU, they drive long-term ECMO circuits for patients with catastrophic organ failure.
  • Ambulatory Surgical Centers (ASCs) & Specialty Clinics: A smaller, highly specialized segment, primarily involving the clinical management and monitoring of patients discharged with permanent, implantable centrifugal VADs.
Value Chain / Supply Chain Analysis

The value chain for Centrifugal Blood Pumps is arguably one of the most technologically demanding and strictly regulated networks in the entire medical device industry.

Upstream: Biocompatible Materials and Microelectronics
  • The manufacturing process begins with the procurement of highly specialized, medical-grade polycarbonates and advanced titanium alloys. The absolute critical requirement is hemocompatibility. The internal surfaces of the pump must be coated with proprietary, biologically inert coatings (such as heparin or advanced synthetic polymers) to prevent the patient's blood from instantly clotting upon contact with the foreign plastic surface.
Midstream: Precision Engineering and Aerodynamics
  • Original Equipment Manufacturers (OEMs) design the internal impeller using advanced computational fluid dynamics (CFD) to ensure blood flows smoothly without stagnant zones where deadly clots could form. The midstream value-add involves the integration of precision electric motors, magnetic levitation coils, and ultra-sensitive flow and pressure sensors into a completely hermetically sealed, fail-safe unit.
Downstream: Clinical Integration and Perfusionist Training
  • The finalized pumps and single-use disposable pump heads are distributed to tertiary cardiac centers. The downstream value chain relies completely on clinical integration. OEMs must provide continuous, exhaustive training to specialized cardiovascular perfusionists and cardiac surgeons to ensure the flawless operation of the pump console during critical life-support scenarios.
Company Profiles

The competitive landscape of the Centrifugal Blood Pump market is a highly consolidated oligopoly, defined by massive global cardiovascular conglomerates that control both the capital hardware and the lucrative disposable supply chains.

Medtronic & Abbott Laboratories
  • Strategic Position: Medtronic and Abbott are the absolute, undisputed titans of global cardiovascular surgery and advanced heart failure management.
  • Market Advantage: Their strategic moat is their comprehensive cardiac portfolios. Medtronic dominates the traditional CPB and ECMO space with highly reliable centrifugal systems that integrate flawlessly with their oxygenators and surgical cannulae. Abbott dictates the permanent Ventricular Assist Device (VAD) market, leveraging their highly advanced, magnetically levitated centrifugal pump technology to provide life-saving destination therapy for end-stage heart failure patients globally.
Terumo Corporation & Getinge
  • Strategic Position: Premier global leaders in extracorporeal life support and cardiovascular technologies.
  • Market Advantage: Terumo (Japan) and Getinge (Sweden) possess massive global footprints in critical care. Getinge’s strategic advantage is its complete dominance in advanced, mobile ECMO systems, providing ultra-compact centrifugal pumps that are the global standard for emergency patient transport. Terumo excels in providing highly integrated, user-friendly CPB consoles and disposable pump heads, capturing massive market share in high-volume cardiac surgery centers.
LivaNova & Baxter International
  • Strategic Position: Highly specialized leaders in cardiopulmonary and acute care technologies.
  • Market Advantage: LivaNova leverages its deep, historical expertise in heart-lung machines, providing highly reliable centrifugal pumps that seamlessly integrate into their massive global install base of CPB consoles. Baxter provides critical support technologies that operate alongside extracorporeal circuits, heavily focusing on acute blood purification.
Opportunities & Challenges

The strategic future of the Centrifugal Blood Pump market balances the explosive growth of ECMO utilization against the severe clinical risks of extracorporeal circulation.

Opportunities
  • The ECMO Paradigm Shift: Historically a treatment of last resort, ECMO is rapidly becoming a standard rescue therapy for severe viral pneumonia, ARDS, and cardiogenic shock. The compounding, global expansion of ICU ECMO capabilities creates a massive, structurally embedded volume opportunity for specialized, long-term centrifugal pump heads and highly advanced drive consoles.
  • Miniaturization and Pediatric Care: There is a massive clinical demand for ultra-miniaturized centrifugal pumps designed specifically for neonates and infants suffering from congenital heart defects. Companies that successfully engineer ultra-low-prime, magnetically levitated pumps for pediatric ECMO and CPB will capture an incredibly lucrative, highly protected niche market.
Challenges
  • Hemolysis and Thrombosis Liabilities: The most severe, existential threat to the market is the inherent danger of mechanical blood pumping. Despite advanced magnetic levitation, spinning an impeller at 3,000 RPM inherently damages red blood cells (hemolysis) and risks catastrophic clot formation (thrombosis), leading to fatal patient strokes. This presents a massive medical-legal liability for the OEM, mandating continuous, highly expensive R&D into fluid dynamics and biocompatible coatings.
  • High Capital and Training Barriers: Advanced centrifugal pump consoles are immensely expensive capital equipment. Furthermore, operating them requires highly trained, specialized clinical personnel (perfusionists). In emerging markets, the lack of capital funding and the severe shortage of trained perfusionists act as massive structural bottlenecks, severely restricting the geographic expansion rate of complex ECMO and VAD therapies.
CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Sources
  3.2.1 Data Sources
  3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Centrifugal Blood Pump Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 HISTORICAL AND FORECAST CENTRIFUGAL BLOOD PUMP MARKET IN NORTH AMERICA (2021-2031)

8.1 Centrifugal Blood Pump Market Size
8.2 Centrifugal Blood Pump Market by End Use
8.3 Competition by Players/Suppliers
8.4 Centrifugal Blood Pump Market Size by Type
8.5 Key Countries Analysis
  8.5.1 United States
  8.5.2 Canada
  8.5.3 Mexico

CHAPTER 9 HISTORICAL AND FORECAST CENTRIFUGAL BLOOD PUMP MARKET IN SOUTH AMERICA (2021-2031)

9.1 Centrifugal Blood Pump Market Size
9.2 Centrifugal Blood Pump Market by End Use
9.3 Competition by Players/Suppliers
9.4 Centrifugal Blood Pump Market Size by Type
9.5 Key Countries Analysis
  9.5.1 Brazil
  9.5.2 Argentina
  9.5.3 Chile
  9.5.4 Peru

CHAPTER 10 HISTORICAL AND FORECAST CENTRIFUGAL BLOOD PUMP MARKET IN ASIA & PACIFIC (2021-2031)

10.1 Centrifugal Blood Pump Market Size
10.2 Centrifugal Blood Pump Market by End Use
10.3 Competition by Players/Suppliers
10.4 Centrifugal Blood Pump Market Size by Type
10.5 Key Countries Analysis
  10.5.1 China
  10.5.2 India
  10.5.3 Japan
  10.5.4 South Korea
  10.5.5 Southest Asia
  10.5.6 Australia & New Zealand

CHAPTER 11 HISTORICAL AND FORECAST CENTRIFUGAL BLOOD PUMP MARKET IN EUROPE (2021-2031)

11.1 Centrifugal Blood Pump Market Size
11.2 Centrifugal Blood Pump Market by End Use
11.3 Competition by Players/Suppliers
11.4 Centrifugal Blood Pump Market Size by Type
11.5 Key Countries Analysis
  11.5.1 Germany
  11.5.2 France
  11.5.3 United Kingdom
  11.5.4 Italy
  11.5.5 Spain
  11.5.6 Belgium
  11.5.7 Netherlands
  11.5.8 Austria
  11.5.9 Poland
  11.5.10 North Europe

CHAPTER 12 HISTORICAL AND FORECAST CENTRIFUGAL BLOOD PUMP MARKET IN MEA (2021-2031)

12.1 Centrifugal Blood Pump Market Size
12.2 Centrifugal Blood Pump Market by End Use
12.3 Competition by Players/Suppliers
12.4 Centrifugal Blood Pump Market Size by Type
12.5 Key Countries Analysis
  12.5.1 Egypt
  12.5.2 Israel
  12.5.3 South Africa
  12.5.4 Gulf Cooperation Council Countries
  12.5.5 Turkey

CHAPTER 13 SUMMARY FOR GLOBAL CENTRIFUGAL BLOOD PUMP MARKET (2021-2026)

13.1 Centrifugal Blood Pump Market Size
13.2 Centrifugal Blood Pump Market by End Use
13.3 Competition by Players/Suppliers
13.4 Centrifugal Blood Pump Market Size by Type

CHAPTER 14 GLOBAL CENTRIFUGAL BLOOD PUMP MARKET FORECAST (2026-2031)

14.1 Centrifugal Blood Pump Market Size Forecast
14.2 Centrifugal Blood Pump Application Forecast
14.3 Competition by Players/Suppliers
14.4 Centrifugal Blood Pump Type Forecast

CHAPTER 15 ANALYSIS OF GLOBAL KEY VENDORS

15.1 Medtronic
  15.1.1 Company Profile
  15.1.2 Main Business and Centrifugal Blood Pump Information
  15.1.3 SWOT Analysis of Medtronic
  15.1.4 Medtronic Centrifugal Blood Pump Revenue, Gross Margin and Market Share (2021-2026)
15.2 Abbott Laboratories
  15.2.1 Company Profile
  15.2.2 Main Business and Centrifugal Blood Pump Information
  15.2.3 SWOT Analysis of Abbott Laboratories
  15.2.4 Abbott Laboratories Centrifugal Blood Pump Revenue, Gross Margin and Market Share (2021-2026)
15.3 Terumo Corporation
  15.3.1 Company Profile
  15.3.2 Main Business and Centrifugal Blood Pump Information
  15.3.3 SWOT Analysis of Terumo Corporation
  15.3.4 Terumo Corporation Centrifugal Blood Pump Revenue, Gross Margin and Market Share (2021-2026)
15.4 Getinge
  15.4.1 Company Profile
  15.4.2 Main Business and Centrifugal Blood Pump Information
  15.4.3 SWOT Analysis of Getinge
  15.4.4 Getinge Centrifugal Blood Pump Revenue, Gross Margin and Market Share (2021-2026)
15.5 LivaNova
  15.5.1 Company Profile
  15.5.2 Main Business and Centrifugal Blood Pump Information
  15.5.3 SWOT Analysis of LivaNova
  15.5.4 LivaNova Centrifugal Blood Pump Revenue, Gross Margin and Market Share (2021-2026)
15.6 Baxter International
  15.6.1 Company Profile
  15.6.2 Main Business and Centrifugal Blood Pump Information
  15.6.3 SWOT Analysis of Baxter International
  15.6.4 Baxter International Centrifugal Blood Pump Revenue, Gross Margin and Market Share (2021-2026)
15.7 Braille Biomedica
  15.7.1 Company Profile
  15.7.2 Main Business and Centrifugal Blood Pump Information
  15.7.3 SWOT Analysis of Braille Biomedica
  15.7.4 Braille Biomedica Centrifugal Blood Pump Revenue, Gross Margin and Market Share (2021-2026)
Please ask for sample pages for full companies list

TABLES AND FIGURES

Table Abbreviation and Acronyms
Table Research Scope of Centrifugal Blood Pump Report
Table Data Sources of Centrifugal Blood Pump Report
Table Major Assumptions of Centrifugal Blood Pump Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Centrifugal Blood Pump Picture
Table Centrifugal Blood Pump Classification
Table Centrifugal Blood Pump Applications
Table Drivers of Centrifugal Blood Pump Market
Table Restraints of Centrifugal Blood Pump Market
Table Opportunities of Centrifugal Blood Pump Market
Table Threats of Centrifugal Blood Pump Market
Table Raw Materials Suppliers
Table Different Production Methods of Centrifugal Blood Pump
Table Cost Structure Analysis of Centrifugal Blood Pump
Table Key End Users
Table Latest News of Centrifugal Blood Pump Market
Table Merger and Acquisition
Table Planned/Future Project of Centrifugal Blood Pump Market
Table Policy of Centrifugal Blood Pump Market
Table 2021-2031 North America Centrifugal Blood Pump Market Size
Figure 2021-2031 North America Centrifugal Blood Pump Market Size and CAGR
Table 2021-2031 North America Centrifugal Blood Pump Market Size by Application
Table 2021-2026 North America Centrifugal Blood Pump Key Players Revenue
Table 2021-2026 North America Centrifugal Blood Pump Key Players Market Share
Table 2021-2031 North America Centrifugal Blood Pump Market Size by Type
Table 2021-2031 United States Centrifugal Blood Pump Market Size
Table 2021-2031 Canada Centrifugal Blood Pump Market Size
Table 2021-2031 Mexico Centrifugal Blood Pump Market Size
Table 2021-2031 South America Centrifugal Blood Pump Market Size
Figure 2021-2031 South America Centrifugal Blood Pump Market Size and CAGR
Table 2021-2031 South America Centrifugal Blood Pump Market Size by Application
Table 2021-2026 South America Centrifugal Blood Pump Key Players Revenue
Table 2021-2026 South America Centrifugal Blood Pump Key Players Market Share
Table 2021-2031 South America Centrifugal Blood Pump Market Size by Type
Table 2021-2031 Brazil Centrifugal Blood Pump Market Size
Table 2021-2031 Argentina Centrifugal Blood Pump Market Size
Table 2021-2031 Chile Centrifugal Blood Pump Market Size
Table 2021-2031 Peru Centrifugal Blood Pump Market Size
Table 2021-2031 Asia & Pacific Centrifugal Blood Pump Market Size
Figure 2021-2031 Asia & Pacific Centrifugal Blood Pump Market Size and CAGR
Table 2021-2031 Asia & Pacific Centrifugal Blood Pump Market Size by Application
Table 2021-2026 Asia & Pacific Centrifugal Blood Pump Key Players Revenue
Table 2021-2026 Asia & Pacific Centrifugal Blood Pump Key Players Market Share
Table 2021-2031 Asia & Pacific Centrifugal Blood Pump Market Size by Type
Table 2021-2031 China Centrifugal Blood Pump Market Size
Table 2021-2031 India Centrifugal Blood Pump Market Size
Table 2021-2031 Japan Centrifugal Blood Pump Market Size
Table 2021-2031 South Korea Centrifugal Blood Pump Market Size
Table 2021-2031 Southeast Asia Centrifugal Blood Pump Market Size
Table 2021-2031 Australia & New Zealand Centrifugal Blood Pump Market Size
Table 2021-2031 Europe Centrifugal Blood Pump Market Size
Figure 2021-2031 Europe Centrifugal Blood Pump Market Size and CAGR
Table 2021-2031 Europe Centrifugal Blood Pump Market Size by Application
Table 2021-2026 Europe Centrifugal Blood Pump Key Players Revenue
Table 2021-2026 Europe Centrifugal Blood Pump Key Players Market Share
Table 2021-2031 Europe Centrifugal Blood Pump Market Size by Type
Table 2021-2031 Germany Centrifugal Blood Pump Market Size
Table 2021-2031 France Centrifugal Blood Pump Market Size
Table 2021-2031 United Kingdom Centrifugal Blood Pump Market Size
Table 2021-2031 Italy Centrifugal Blood Pump Market Size
Table 2021-2031 Spain Centrifugal Blood Pump Market Size
Table 2021-2031 Belgium Centrifugal Blood Pump Market Size
Table 2021-2031 Netherlands Centrifugal Blood Pump Market Size
Table 2021-2031 Austria Centrifugal Blood Pump Market Size
Table 2021-2031 Poland Centrifugal Blood Pump Market Size
Table 2021-2031 North Europe Centrifugal Blood Pump Market Size
Table 2021-2031 MEA Centrifugal Blood Pump Market Size
Figure 2021-2031 MEA Centrifugal Blood Pump Market Size and CAGR
Table 2021-2031 MEA Centrifugal Blood Pump Market Size by Application
Table 2021-2026 MEA Centrifugal Blood Pump Key Players Revenue
Table 2021-2026 MEA Centrifugal Blood Pump Key Players Market Share
Table 2021-2031 MEA Centrifugal Blood Pump Market Size by Type
Table 2021-2031 Egypt Centrifugal Blood Pump Market Size
Table 2021-2031 Israel Centrifugal Blood Pump Market Size
Table 2021-2031 South Africa Centrifugal Blood Pump Market Size
Table 2021-2031 Gulf Cooperation Council Countries Centrifugal Blood Pump Market Size
Table 2021-2031 Turkey Centrifugal Blood Pump Market Size
Table 2021-2026 Global Centrifugal Blood Pump Market Size by Region
Table 2021-2026 Global Centrifugal Blood Pump Market Size Share by Region
Table 2021-2026 Global Centrifugal Blood Pump Market Size by Application
Table 2021-2026 Global Centrifugal Blood Pump Market Share by Application
Table 2021-2026 Global Centrifugal Blood Pump Key Vendors Revenue
Figure 2021-2026 Global Centrifugal Blood Pump Market Size and Growth Rate
Table 2021-2026 Global Centrifugal Blood Pump Key Vendors Market Share
Table 2021-2026 Global Centrifugal Blood Pump Market Size by Type
Table 2021-2026 Global Centrifugal Blood Pump Market Share by Type
Table 2026-2031 Global Centrifugal Blood Pump Market Size by Region
Table 2026-2031 Global Centrifugal Blood Pump Market Size Share by Region
Table 2026-2031 Global Centrifugal Blood Pump Market Size by Application
Table 2026-2031 Global Centrifugal Blood Pump Market Share by Application
Table 2026-2031 Global Centrifugal Blood Pump Key Vendors Revenue
Figure 2026-2031 Global Centrifugal Blood Pump Market Size and Growth Rate
Table 2026-2031 Global Centrifugal Blood Pump Key Vendors Market Share
Table 2026-2031 Global Centrifugal Blood Pump Market Size by Type
Table 2026-2031 Centrifugal Blood Pump Global Market Share by Type
Table Medtronic Information
Table SWOT Analysis of Medtronic
Table 2021-2026 Medtronic Centrifugal Blood Pump Revenue Gross Profit Margin
Figure 2021-2026 Medtronic Centrifugal Blood Pump Revenue and Growth Rate
Figure 2021-2026 Medtronic Centrifugal Blood Pump Market Share
Table Abbott Laboratories Information
Table SWOT Analysis of Abbott Laboratories
Table 2021-2026 Abbott Laboratories Centrifugal Blood Pump Revenue Gross Profit Margin
Figure 2021-2026 Abbott Laboratories Centrifugal Blood Pump Revenue and Growth Rate
Figure 2021-2026 Abbott Laboratories Centrifugal Blood Pump Market Share
Table Terumo Corporation Information
Table SWOT Analysis of Terumo Corporation
Table 2021-2026 Terumo Corporation Centrifugal Blood Pump Revenue Gross Profit Margin
Figure 2021-2026 Terumo Corporation Centrifugal Blood Pump Revenue and Growth Rate
Figure 2021-2026 Terumo Corporation Centrifugal Blood Pump Market Share
Table Getinge Information
Table SWOT Analysis of Getinge
Table 2021-2026 Getinge Centrifugal Blood Pump Revenue Gross Profit Margin
Figure 2021-2026 Getinge Centrifugal Blood Pump Revenue and Growth Rate
Figure 2021-2026 Getinge Centrifugal Blood Pump Market Share
Table LivaNova Information
Table SWOT Analysis of LivaNova
Table 2021-2026 LivaNova Centrifugal Blood Pump Revenue Gross Profit Margin
Figure 2021-2026 LivaNova Centrifugal Blood Pump Revenue and Growth Rate
Figure 2021-2026 LivaNova Centrifugal Blood Pump Market Share
Table Baxter International Information
Table SWOT Analysis of Baxter International
Table 2021-2026 Baxter International Centrifugal Blood Pump Revenue Gross Profit Margin
Figure 2021-2026 Baxter International Centrifugal Blood Pump Revenue and Growth Rate
Figure 2021-2026 Baxter International Centrifugal Blood Pump Market Share
Table Braille Biomedica Information
Table SWOT Analysis of Braille Biomedica
Table 2021-2026 Braille Biomedica Centrifugal Blood Pump Revenue Gross Profit Margin
Figure 2021-2026 Braille Biomedica Centrifugal Blood Pump Revenue and Growth Rate
Figure 2021-2026 Braille Biomedica Centrifugal Blood Pump Market Share
......


More Publications